Trxade Health (Trxade Health) Cash And Cash Equivalents : $0.15 Mil (As of Dec. 2023)

View and export this data going back to 2008. Start your Free Trial

What is Trxade Health Cash And Cash Equivalents?

Trxade Health's quarterly cash and cash equivalents declined from Jun. 2023 ($0.75 Mil) to Sep. 2023 ($0.03 Mil) but then increased from Sep. 2023 ($0.03 Mil) to Dec. 2023 ($0.15 Mil).

Trxade Health's annual cash and cash equivalents declined from Dec. 2021 ($3.12 Mil) to Dec. 2022 ($1.10 Mil) and declined from Dec. 2022 ($1.10 Mil) to Dec. 2023 ($0.15 Mil).

Trxade Health Cash And Cash Equivalents Historical Data

The historical data trend for Trxade Health's Cash And Cash Equivalents can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Trxade Health Cash And Cash Equivalents Chart

Trxade Health Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Cash And Cash Equivalents

Get a 7-Day Free Trial

2.87

5.92

3.12

1.10

0.15

Trxade Health Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Cash And Cash Equivalents	Get a 7-Day Free Trial															1.10	1.19	0.75	0.03	0.15

Trxade Health Cash And Cash Equivalents Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Trxade Health (NAS:MEDS) Cash And Cash Equivalents Explanation

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.

Be Aware

Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.

Trxade Health Cash And Cash Equivalents Related Terms

Thank you for viewing the detailed overview of Trxade Health's Cash And Cash Equivalents provided by GuruFocus.com. Please click on the following links to see related term pages.

Trxade Health (Trxade Health) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Trxade Health Inc (NAS:MEDS) » Definitions » Cash And Cash Equivalents

Comparable Companies

Traded in Other Exchanges

N/A

Address

2420 Brunello Trace., Lutz, FL, USA, 33558

Website

https://www.rx.trxade.com

Trxade Health Inc is a health service IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey, and patient engagement in the U.S. Its product and services include Integra Pharma Solutions, LLC, Community Specialty Pharmacy, LLC, Delivmeds.com, Bonum Health Hub and Application, and others. its business is classified into reportable segments which are Trxade, Inc, Community Specialty Pharmacy, LLC, Integra Pharma, LLC, and Other, and the majority of the revenue comes from Trxade, Inc.

Executives

A. Jeffrey Newell	director	645 CAMP DIXIE RD, PASCOAG RI 02859
Donald G. Fell	director	17537 DARBY LANE, LUTZ FL 33558
Janet Huffman	officer: CFO, PAO, PFO	5317 FRUITVILLE RD SUITE 6, SARASOTA FL 34232
Michael L Peterson	director	17 CANARY COURT, DANVILLE CA 94526
Christine L. Jennings	director	3840 LAND O' LAKES BLVD., LAND O' LAKES FL 34639
Prashant Patel	director, 10 percent owner, officer: President	17537 DARBY LANE, LUTZ FL 33558
Pamela Tenaerts	director	PO BOX 15012, SARASOTA FL 34277
Gary Augusta	director	700 NORTH BRAND BLVD., SUITE 1400, GLENDALE CA 91203
Howard A. Doss	officer: CFO	17537 DARBY LANE, LUTZ FL 90067
Surendra K Ajjarapu	director, 10 percent owner, officer: CEO	8604 BUTTON BUSH CT, TAMPA FL 33647
Donald V. Almeida	director	1115 GUNN HIGHWAY, SUITE 202, ODESSA FL 33556
Charles L Pope	director	4902 EISENHOWER BOULEVARD, TAMPA FL 33634
Sandhya Ajjarapu	10 percent owner	17537 DARBY LANE, LUTZ FL 33558